Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC
about
Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC
description
clinical trial
@en
klinisch onderzoek
@nl
name
Randomized Phase-II Study of N ...... nd Advanced Non-clear Cell RCC
@en
type
label
Randomized Phase-II Study of N ...... nd Advanced Non-clear Cell RCC
@en
prefLabel
Randomized Phase-II Study of N ...... nd Advanced Non-clear Cell RCC
@en
P6153
P1050
P1476
A Phase 2, Randomized, Open-La ...... Renal Cell Carcinoma (nccRCC)
@en
P1813
SUNIFORECAST
@en
P3098
NCT03075423
P580
2017-11-01T00:00:00Z
P582
2021-12-31T00:00:00Z